Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-25

Clinical Trial Update: A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of dapagliflozin on heart work, heart nutrient uptake, and heart muscle efficiency in adults with type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2020-03-25